REDUNDANCIES are being sought at 3M’s Clitheroe plant at Upbrooks.
The diversified technology company has announced that it has commenced a 90-day period of consultation with employees at its Clitheroe site, which manufactures valves and components for asthma inhalers.
The decision follows a comprehensive review aimed at strengthening the company’s competiveness in an uncertain economic climate. That review has resulted in proposals which, if accepted, could lead to the loss of 21 positions at the Clitheroe site out of a total workforce of 163 employees.
Announcing the consultation, Stephen Murray, Plant Manager for 3M’s Clitheroe site, said: “We recognise the impact that this proposed restructuring will have and it is always difficult to make decisions that affect people’s livelihoods.
“However, we believe that moving to a new business model that reduces our costs by streamlining our operation will offer the best growth opportunity for the business going forward.
“We will be consulting employees in a professional, honest, open and fair manner. We will be sharing with them the thought processes that have led us to believe that this is the best option to grow the business – and all employees will have an opportunity to ask questions and contribute views.”
3M employees at Clitheroe will be briefed on the outcome of the consultation process when discussions have been concluded in May.